XML 35 R87.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended 44 Months Ended
Apr. 26, 2016
Mar. 31, 2018
Apr. 30, 2016
Mar. 31, 2014
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2019
Jan. 31, 2011
May 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Contractual term         10 years          
Aggregate intrinsic value of stock options exercised         $ 1,048 $ 4,825 $ 10,974      
Unamortized stock-based compensation         $ 4,588     $ 4,588    
Weighted-average vesting period         2 years 10 months 24 days          
Cash dividend (in dollars per share) $ 1.30                  
Cash dividend $ 28,886                  
Unrecognized non-cash compensation costs $ 38,877                  
Compensation costs recognition period, after plan modifications 12 months                  
Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period         3 years          
Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period         5 years          
American Renal Holdings Inc. 2005 Equity Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options to purchase outstanding (in shares)         0     0    
Common stock reserved for issuance and remaining for future equity grants (in shares)         0     0    
American Renal Associates Holdings, Inc. 2010 Stock Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options to purchase outstanding (in shares)         3,519,887     3,519,887    
Common stock reserved for issuance and remaining for future equity grants (in shares)         0     0   3,606,251
Authorized additional stock options (in shares)       1,627,258            
American Renal Associates Holdings, Inc. 2011 Stock Option Plan for Nonemployee Directors                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options to purchase outstanding (in shares)         34,350     34,350    
Common stock reserved for issuance and remaining for future equity grants (in shares)         0     0 100,000  
2016 Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock reserved for issuance and remaining for future equity grants (in shares)         1,437,563     1,437,563    
Authorized additional stock options (in shares)     4,000,000              
Common stock | 2016 Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Nonvested (in shares)         1,248,909     1,248,909    
Restricted stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Nonvested (in shares)         579,283 441,063   579,283    
Unamortized stock-based compensation         $ 4,668     $ 4,668    
Weighted-average vesting period         1 year          
Awards granted (in shares)         324,801          
Awards granted (in USD per share)         $ 10.19          
Fair value of restricted stock vested         $ 2,950 $ 1,701 440      
Restricted stock | 2016 Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Nonvested (in shares)         579,283     579,283    
Market and Performance Based Vesting                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unamortized stock-based compensation         $ 192     $ 192    
Performance and Time Based Vesting                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unamortized stock-based compensation         $ 4,397     $ 4,397    
Executive | Restricted stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period   3 years                
Weighted-average vesting period         3 years          
Awards granted (in shares)   95,000     51,500          
Awards granted (in USD per share)   $ 22.33     $ 10.19          
Vested Option Stockholders                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equivalent adjustments in the form of cash dividend equivalent payments (in dollars per share)               $ 1.30    
Equitable adjustments in the form of cash dividend equivalent payments               $ 5,391    
Vested Option Stockholders | Term Loan Holdings LLC                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equitable adjustments in the form of cash dividend equivalent payments               2,524    
Unvested Option Stockholders                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equitable adjustments in the form of cash dividend equivalent payments               $ 1,247    
IPO                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock compensation due to modification             $ 11,749